View Older Stories View More Recent Stories
-
Rattler Midstream LP (RTLR) Announces Proposed 33.33M Share IPO Between $16-$19/Sh
-
UPDATE: RBC Capital Starts HOOKIPA Pharma Inc. (HOOK) at Outperform
-
Rattler Midstream LP, a Subsidiary of Diamondback Energy, Inc., Announces Launch of Initial Public Offering
-
Rattler Midstream LP, a Subsidiary of Diamondback Energy, Inc., Announces Launch of Initial Public Offering
-
UPDATE: RBC Capital Starts Brigham Minerals Inc. (MNRL) at Outperform
-
RBC Capital Starts Turning Point Therapeutics Inc. (TPTX) at Outperform
-
RBC Capital Downgrades Royal Gold (RGLD) to Sector Perform
-
The Data Centre Industry Moves Into a New Phase of Heavy Investment Says BroadGroup Ahead of Finvest Summit
-
Hansa Biopharma to Participate in UBS Global Healthcare Conference and RBC Capital Markets Global Healthcare Conference in New York City
-
RBC Capital Downgrades Kinder Morgan Canada Ltd. (KML:CN) (KMLGF) to Sector Perform
-
Form 13F-NT RBC Capital Markets, For: Mar 31
-
Form 13F-NT RBC Capital Markets Arbi For: Mar 31
-
Surgery Partners, Inc. to Present at Upcoming Investor Conferences
-
Intercept to Present at Upcoming Investor Conferences in May
-
Mimecast Limited (MIME) PT Raised to $55 at RBC Capital
-
Uber (UBER) IPO Opens at $42, Below $45 Pricing
-
HealthEquity Sets Date to Announce First Quarter Results
-
Intercept Pharma (ICPT) Prices Offerings of Common Stock and Convertible Senior Notes due 2026
-
Intercept Pharmaceuticals Announces Pricing of Offerings of Common Stock and Convertible Senior Notes due 2026
-
'Elephant in the Room' of Humana (HUM) NDR was Possible Centene (CNC) Offer; Sees 'Low Probability' - RBC
-
Zillow Group (ZG) PT Raised to $42 at RBC Capital
-
TrueCar (TRUE) PT Lowered to $8 at RBC Capital
-
TransEnterix (TRXC) PT Lowered to $3 at RBC Capital
-
The Ensign Group Inc. (ENSG) PT Raised to $60 at RBC Capital
-
Symantec (SYMC) PT Lowered to $22 at RBC Capital
-
Puma Biotechnology (PBYI) PT Lowered to $22 at RBC Capital
-
Osmotica (OSMT) PT Lowered to $11 at RBC Capital
-
Inovio Pharmaceuticals (INO) PT Lowered to $11 at RBC Capital
-
Denbury Resources (DNR) PT Lowered to $2 at RBC Capital
-
CarGurus Inc. (CARG) PT Raised to $56 at RBC Capital
-
Amneal Pharmaceuticals (AMRX) PT Lowered to $17 at RBC Capital
-
Akebia Therapeutics (AKBA) PT Lowered to $11 at RBC Capital
-
Realty Income Closes 11.0 Million Share Common Stock Offering
-
Uber (UBER) Confirms Pricing 180M Share IPO at $45
-
Uber Announces Pricing of Initial Public Offering
-
Lightyear Capital and PSP Investments Announce Sale of Advisor Group to Reverence Capital Partners
-
Xeris Pharmaceuticals Announces First Quarter 2019 Financial Results and Highlights Its Pipeline
-
Xeris Pharmaceuticals Announces First Quarter 2019 Financial Results and Highlights Its Pipeline
-
Jagged Peak Energy Inc. Announces First Quarter 2019 Financial and Operating Results
-
BroadGroup Announces Global Investors Gather in Monaco to Assess Risk and Outlook for Datacenter, Cloud and Edge at Finvest Summit 2019
-
Chevron drops Anadarko takeover battle after Occidental raises bid
-
Gamida Cell to Participate in Two Upcoming Healthcare Conferences in New York City
-
Agile Therapeutics to Present at the 2019 RBC Capital Markets Global Healthcare Conference
-
Agile Therapeutics to Present at the 2019 RBC Capital Markets Global Healthcare Conference
-
Optinose Reports First Quarter 2019 Financial ResultsĀ and Recent Operational Highlights
-
Optinose Reports First Quarter 2019 Financial ResultsĀ and Recent Operational Highlights
-
Voya Financial (VOYA) PT Raised to $60 at RBC Capital
-
Upwork Inc. (UPWK) PT Lowered to $25 at RBC Capital
-
Thomson Reuters (TRI) PT Raised to $66 at RBC Capital
-
Surgery Partners (SGRY) PT Lowered to $15 at RBC Capital

